Source link : https://thenewsguy.net/2026/03/25/astrazeneca-expands-us-footprint-with-4-5-billion-virginia-manufacturing-investment/

astrazeneca, the prominent global biopharmaceutical company, has announced a critically important expansion of its manufacturing capabilities in the United States, revealing plans to increase its investment in a Virginia facility to a groundbreaking $4.5 billion.This strategic move underscores the company’s commitment to bolstering domestic production capacities, enhancing supply chain resilience, and supporting pharmaceutical innovation. The […]

—-

Author : jeepeg

Publish date : 2026-03-25 09:40:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version